[
    "{\"step_by_step_thinking\": \"To determine the recently approved drug by FDA for the treatment of Lennox-Gastaut syndrome, we need to review the information provided in the relevant documents. Document [0] mentions that clobazam was approved by the FDA in 2011 as adjunctive treatment for Lennox-Gastaut syndrome. However, none of the options provided match clobazam. Document [12] states that rufinamide was approved in November 2008 as an adjunctive therapy for Lennox-Gastaut syndrome. Therefore, the recently approved drug by FDA for the treatment of Lennox-Gastaut syndrome is Rufinamide.\", \"answer_choice\": \"D\"}"
]